In prostate cancer, the synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP), which suppresses APOBEC-dependent mutagenesis, is frequently lost. The gene discussed is SYNCRIP; the disease is prostate carcinoma.